Chinese Vaccine Developers' Latest COVID Shots Target XBB Subvariants

 
• By Dexter Jie Yan

Chinese vaccine companies WestVac, Sinocelltech and Walvax/RNACure are leading domestic efforts to develop new shots targeting emerging SARS-CoV-2 subvariants.

COVID XBB
The Omicron XBB.1.5 sublineage had become the most prevalent COVID-19 strain in China by mid-year • Source: Shutterstock

More from China

More from Focus On Asia